SIRPα blockade improves the antitumor immunity of radiotherapy in colorectal cancer
Abstract High-dose hypofractionated radiotherapy (HRT) is an important anticancer treatment modality that activates antitumor host immune responses. However, HRT for oligometastases of colorectal cancer (CRC) has shown frustrating results in the clinic. As part of immune evasion, myeloid cells expre...
Main Authors: | Kai Ji, Yuhan Zhang, Shengpeng Jiang, Lin Sun, Baozhong Zhang, Dongzhi Hu, Jun Wang, Lujun Zhao, Ping Wang, Zhen Tao |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2023-06-01
|
Series: | Cell Death Discovery |
Online Access: | https://doi.org/10.1038/s41420-023-01472-4 |
Similar Items
-
Overcoming immunotherapeutic resistance in PDAC: SIRPα-CD47 blockade
by: Abdullahi Alausa, et al.
Published: (2022-07-01) -
A SIRPα‐Fc fusion protein enhances the antitumor effect of oncolytic adenovirus against ovarian cancer
by: Yao Huang, et al.
Published: (2020-03-01) -
Intratumoral SIRPα-deficient macrophages activate tumor antigen-specific cytotoxic T cells under radiotherapy
by: Zhen Bian, et al.
Published: (2021-05-01) -
Liposome-Based Co-Immunotherapy with TLR Agonist and CD47-SIRPα Checkpoint Blockade for Efficient Treatment of Colon Cancer
by: Rui Chang, et al.
Published: (2023-03-01) -
Development of therapeutic antibodies against SIRPα
by: Chan, Lynn Xing Hui
Published: (2017)